ReP USP - Resultado da busca

Artigo de periodico
Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? (2023)
Zanetti, Maria Olívia Barboza; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, ADESÃO À MEDICAÇÃO, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance?. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 348-357, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073469. Acesso em: 12 maio 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? Journal of Oncology Pharmacy Practice, 29( 2), 348-357. doi:10.1177/10781552211073469
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 maio 12 ] Available from: https://doi.org/10.1177/10781552211073469
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 maio 12 ] Available from: https://doi.org/10.1177/10781552211073469
Artigo de periodico
Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team (2023)
Zanetti, Maria Olívia Barboza; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, HOSPITALIZAÇÃO, SERVIÇOS FARMACÊUTICOS, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 375-385, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073797. Acesso em: 12 maio 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, 29( 2), 375-385. doi:10.1177/10781552211073797
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 maio 12 ] Available from: https://doi.org/10.1177/10781552211073797
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 maio 12 ] Available from: https://doi.org/10.1177/10781552211073797
Artigo de periodico
Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge (2022)
Bortolotti, Fernanda; Innocentini, Lara Maria ALencar Ramos ; Macedo, Mayra Dorigan de; Ferrari, Tatiane Cristina; Haddad, Simone Kashima ; Covas, Dimas Tadeu ; Ricz, Hilton Marcos Alves ; Simões, Belinda Pinto ; Cunha, Renato Luiz Guerino ; Macedo, Leandro Dorigan de
Source: Hematology, Transfusion and Cell Therapy. Unidades: FORP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, MUCOSA ORAL, MYCOPLASMA, INFECÇÃO DA FERIDA OPERATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLOTTI, Fernanda et al. Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge. Hematology, Transfusion and Cell Therapy, v. 44, n. 2, p. 259-263, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2020.08.002. Acesso em: 12 maio 2024.
APA
Bortolotti, F., Innocentini, L. M. A. L. R., Macedo, M. D. de, Ferrari, T. C., Haddad, S. K., Covas, D. T., et al. (2022). Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge. Hematology, Transfusion and Cell Therapy, 44( 2), 259-263. doi:10.1016/j.htct.2020.08.002
NLM
Bortolotti F, Innocentini LMALR, Macedo MD de, Ferrari TC, Haddad SK, Covas DT, Ricz HMA, Simões BP, Cunha RLG, Macedo LD de. Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 2): 259-263.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.htct.2020.08.002
Vancouver
Bortolotti F, Innocentini LMALR, Macedo MD de, Ferrari TC, Haddad SK, Covas DT, Ricz HMA, Simões BP, Cunha RLG, Macedo LD de. Oral mucosa infection by Mycoplasma salivarium in a patient with chronic graft-versus-host disease: a diagnostic challenge [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 2): 259-263.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.htct.2020.08.002
Artigo de periodico
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients (2022)
Jarduli, Luciana Ribeiro; Azevedo, Júlia Teixeira Cottas de; Clave, Emmanuel; Costa, Thalita Cristina de Mello; Arruda, Lucas Coelho Marliére; Fournier, Isabelle; Palma, Patricia Vianna Bonini; Lima, Keli Cristina de; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Pieroni, Fabiano; Cunha, Renato Luiz Guerino; Darrigo Júnior, Luiz Guilherme; Grecco, Carlos Eduardo Setanni; Covas, Dimas Tadeu; Pinto, Ana Cristina Silva; De Santis, Gil Cunha; Simões, Belinda Pinto; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Clinical & Translational Immunology. Unidades: FMRP, FCFRP, FM
Subjects: CÉLULAS-TRONCO, HOMEOSTASE, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDULI, Luciana Ribeiro et al. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, v. 11, n. 4, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1002/cti2.1389. Acesso em: 12 maio 2024.
APA
Jarduli, L. R., Azevedo, J. T. C. de, Clave, E., Costa, T. C. de M., Arruda, L. C. M., Fournier, I., et al. (2022). Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, 11( 4), 1-16. doi:10.1002/cti2.1389
NLM
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 maio 12 ] Available from: https://doi.org/10.1002/cti2.1389
Vancouver
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 maio 12 ] Available from: https://doi.org/10.1002/cti2.1389
Artigo de periodico
Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients (2021)
Lima-Júnior, João R.; Arruda, Lucas C. M.; Gonçalves, Maynara Santana; Dias, Juliana B. E.; Moraes, Daniela A.; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, INTERLEUCINAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, João R. et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, v. 60, n. 12, p. 5538–5548, 2021Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab257. Acesso em: 12 maio 2024.
APA
Lima-Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Dias, J. B. E., Moraes, D. A., Covas, D. T., et al. (2021). Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, 60( 12), 5538–5548. doi:10.1093/rheumatology/keab257
NLM
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 maio 12 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Vancouver
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 maio 12 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Artigo de periodico
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party (2021)
Henes, Joerg; Oliveira, Maria Carolina; Labopin, Myriam; Badoglio, Manuela; Scherer, Hans Ulrich; Del Papa, Nicoletta; Daikeler, Thomas; Schmalzing, Marc; Schroers, Roland; Martin, Thierry; Pugnet, Gregory; Simões, Belinda Pinto; Michonneau, David; Marijt, Erik W. A.; Lioure, Bruno; Bay, Jacques Olivier; Snowden, John A.; Rovira, Montserrat; Huynh, Anne; Onida, Francesco; Kanz, Lothar; Marjanovic, Zora; Farge, Dominique
Source: Haematologica: the hematology journal. Unidade: FMRP
Subjects: ENVELHECIMENTO, DOENÇAS AUTOIMUNES, MEDULA ÓSSEA, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, ESTUDOS PROSPECTIVOS, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HENES, Joerg et al. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica: the hematology journal, v. 106, n. 2, p. 375-383, 2021Tradução . . Disponível em: https://doi.org/10.3324/haematol.2019.230128. Acesso em: 12 maio 2024.
APA
Henes, J., Oliveira, M. C., Labopin, M., Badoglio, M., Scherer, H. U., Del Papa, N., et al. (2021). Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica: the hematology journal, 106( 2), 375-383. doi:10.3324/haematol.2019.230128
NLM
Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T, Pugnet G, Simões BP, Michonneau D, Marijt EWA, Lioure B, Bay JO, Snowden JA, Rovira M, Huynh A, Onida F, Kanz L, Marjanovic Z, Farge D. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party [Internet]. Haematologica: the hematology journal. 2021 ; 106( 2): 375-383.[citado 2024 maio 12 ] Available from: https://doi.org/10.3324/haematol.2019.230128
Vancouver
Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, Daikeler T, Schmalzing M, Schroers R, Martin T, Pugnet G, Simões BP, Michonneau D, Marijt EWA, Lioure B, Bay JO, Snowden JA, Rovira M, Huynh A, Onida F, Kanz L, Marjanovic Z, Farge D. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party [Internet]. Haematologica: the hematology journal. 2021 ; 106( 2): 375-383.[citado 2024 maio 12 ] Available from: https://doi.org/10.3324/haematol.2019.230128
Artigo de periodico
Epidemiology of invasive fungal disease in haematologic patients (2021)
Souza, Luciana; Nouér, Simone A.; Morales, Hugo; Simões, Belinda Pinto ; Solza, Cristiana; Queiroz‐Telles, Flavio; Nucci, Marcio
Source: Mycoses. Unidade: FMRP
Subjects: LEUCEMIA, LEUCEMIA MIELOIDE AGUDA, EPIDEMIOLOGIA, DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luciana et al. Epidemiology of invasive fungal disease in haematologic patients. Mycoses, v. 64, n. 3, p. 252-256, 2021Tradução . . Disponível em: https://doi.org/10.1111/myc.13205. Acesso em: 12 maio 2024.
APA
Souza, L., Nouér, S. A., Morales, H., Simões, B. P., Solza, C., Queiroz‐Telles, F., & Nucci, M. (2021). Epidemiology of invasive fungal disease in haematologic patients. Mycoses, 64( 3), 252-256. doi:10.1111/myc.13205
NLM
Souza L, Nouér SA, Morales H, Simões BP, Solza C, Queiroz‐Telles F, Nucci M. Epidemiology of invasive fungal disease in haematologic patients [Internet]. Mycoses. 2021 ; 64( 3): 252-256.[citado 2024 maio 12 ] Available from: https://doi.org/10.1111/myc.13205
Vancouver
Souza L, Nouér SA, Morales H, Simões BP, Solza C, Queiroz‐Telles F, Nucci M. Epidemiology of invasive fungal disease in haematologic patients [Internet]. Mycoses. 2021 ; 64( 3): 252-256.[citado 2024 maio 12 ] Available from: https://doi.org/10.1111/myc.13205
Artigo de periodico
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? (2021)
Silveira, Douglas Rafaele Almeida; Coelho-Silva, Juan L.; Silva, Wellington Fernandes da; Vallance, Grant; Pereira-Martins, Diego A; Madeira, Maria I. A.; Figueredo-Pontes, Lorena L.; Velloso, Elvira Deolinda Rodrigues Pereira; Simões, Belinda Pinto; Peniket, Andy; Danby, Robert; Rego, Eduardo Magalhães; Vyas, Paresh; Traina, Fabiola; Bendit, Israel; Quek, Lynn; Rocha, Vanderson
Source: Leukemia and Lymphoma. Unidades: FMRP, FM
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTES, CÉLULAS-TRONCO, HEMATOPOESE, LEUCEMIA MIELOIDE AGUDA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Douglas Rafaele Almeida et al. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ?. Leukemia and Lymphoma, v. 62, n. 1, p. 147-157, 2021Tradução . . Disponível em: https://doi.org/10.1080/10428194.2020.1827252. Acesso em: 12 maio 2024.
APA
Silveira, D. R. A., Coelho-Silva, J. L., Silva, W. F. da, Vallance, G., Pereira-Martins, D. A., Madeira, M. I. A., et al. (2021). A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? Leukemia and Lymphoma, 62( 1), 147-157. doi:10.1080/10428194.2020.1827252
NLM
Silveira DRA, Coelho-Silva JL, Silva WF da, Vallance G, Pereira-Martins DA, Madeira MIA, Figueredo-Pontes LL, Velloso EDRP, Simões BP, Peniket A, Danby R, Rego EM, Vyas P, Traina F, Bendit I, Quek L, Rocha V. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? [Internet]. Leukemia and Lymphoma. 2021 ; 62( 1): 147-157.[citado 2024 maio 12 ] Available from: https://doi.org/10.1080/10428194.2020.1827252
Vancouver
Silveira DRA, Coelho-Silva JL, Silva WF da, Vallance G, Pereira-Martins DA, Madeira MIA, Figueredo-Pontes LL, Velloso EDRP, Simões BP, Peniket A, Danby R, Rego EM, Vyas P, Traina F, Bendit I, Quek L, Rocha V. A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings ? [Internet]. Leukemia and Lymphoma. 2021 ; 62( 1): 147-157.[citado 2024 maio 12 ] Available from: https://doi.org/10.1080/10428194.2020.1827252
Artigo de periodico
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia (2021)
Ribeiro, Renata Scopim ; Machado Neto, João Agostinho ; Eide, Christopher A. ; Silva, Juan Luiz Coelho da ; Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina; Scheucher, Priscila Santos ; Stevens, Samantha L. Savage ; Campos, Paula de Melo; Saad, Sara T. Olalla ; Palma, Leonardo de Carvalho ; Pontes, Lorena Lobo de Figueiredo ; Simões, Belinda Pinto ; Rego, Eduardo Magalhães ; Tognon, Cristina E. ; Druker, Brian J. ; Traina, Fabiola
Source: Investigational New Drugs. Unidades: ICB, FMRP, FM
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE, INSULINA, ANTINEOPLÁSICOS, PROTEÍNAS QUINASES, CÉLULAS SANGUÍNEAS, PROLIFERAÇÃO CELULAR, APOPTOSE, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Renata Scopim et al. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, v. 39, n. 3, p. 736-746, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10637-020-01028-8. Acesso em: 12 maio 2024.
APA
Ribeiro, R. S., Machado Neto, J. A., Eide, C. A., Silva, J. L. C. da, Fenerich, B. A., Fernandes, J. C., et al. (2021). NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, 39( 3), 736-746. doi:10.1007/s10637-020-01028-8
NLM
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 maio 12 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Vancouver
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 maio 12 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Artigo de periodico-carta/editorial
Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience (2020)
De Santis, Gil Cunha; Costa, Thalita Cristina de Mello; Santos, Flávia Leite Souza ; Pinto, Ana Cristina Silva ; Stracieri, Ana B. P. L.; Pieroni, Fabiano; Darrigo Júnior, Luiz Guilherme; Faria, Joana T. B.; Grecco, Carlos E. S.; Moraes, Daniela A.; Dias, Juliana B.; Rodrigues, Maria Carolina de Oliveira ; Covas, Dimas Tadeu ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto
Source: British Journal of Haematology. Unidade: FMRP
Subjects: TRANSFUSÃO DE SANGUE, ANEMIA FALCIFORME, CÉLULAS-TRONCO, ANTICORPOS, GRUPOS SANGUÍNEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE SANTIS, Gil Cunha et al. Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience. British Journal of Haematology. West Sussex: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bjh.16703. Acesso em: 12 maio 2024. , 2020
APA
De Santis, G. C., Costa, T. C. de M., Santos, F. L. S., Pinto, A. C. S., Stracieri, A. B. P. L., Pieroni, F., et al. (2020). Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience. British Journal of Haematology. West Sussex: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/bjh.16703
NLM
De Santis GC, Costa TC de M, Santos FLS, Pinto ACS, Stracieri ABPL, Pieroni F, Darrigo Júnior LG, Faria JTB, Grecco CES, Moraes DA, Dias JB, Rodrigues MC de O, Covas DT, Cunha RLG, Simões BP. Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience [Internet]. British Journal of Haematology. 2020 ; 190( 5): e295-e297.[citado 2024 maio 12 ] Available from: https://doi.org/10.1111/bjh.16703
Vancouver
De Santis GC, Costa TC de M, Santos FLS, Pinto ACS, Stracieri ABPL, Pieroni F, Darrigo Júnior LG, Faria JTB, Grecco CES, Moraes DA, Dias JB, Rodrigues MC de O, Covas DT, Cunha RLG, Simões BP. Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation [Carta]: a single‐institution experience [Internet]. British Journal of Haematology. 2020 ; 190( 5): e295-e297.[citado 2024 maio 12 ] Available from: https://doi.org/10.1111/bjh.16703
Artigo de periodico
Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease (2020)
Tozatto-Maio, Karina; Girot, Robert; Ly, Indou Deme ; Silva-Pinto, Ana Cristina; Rocha, Vanderson Geraldo ; Fernandes, Francisco José de Almeida; Diagne, Ibrahima; Benzerara, Yahia ; Dinardo, Carla Luana ; Soler, Júlia Maria Pavan ; Haddad, Simone Kashima ; Araujo, Itauá Leston ; Kenzey, Chantal ; Fonseca, Guilherme Henrique Hencklain; Sandoval, Evandra Strazza Rodrigues ; Volt, Fernanda; Jarduli, Luciana; Ruggeri, Annalisa ; Mariaselvam, Christina ; Gualandro, Sandra Fátima Menosi ; Rafii, Hanadi ; Cappelli, Barbara ; Nogueira, Felipe Melo; Scigliuolo, Graziana Maria; Cunha, Renato Luiz Guerino ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Simões, Belinda Pinto ; Gluckman, Eliane ; Tamouza, Ryad
Source: Frontiers in Immunology. Unidades: FMRP, FM, FCFRP, IME
Subjects: ANEMIA FALCIFORME, REGRESSÃO LOGÍSTICA, R (SOFTWARE ESTATÍSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO-MAIO, Karina et al. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Frontiers in Immunology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.02041. Acesso em: 12 maio 2024.
APA
Tozatto-Maio, K., Girot, R., Ly, I. D., Silva-Pinto, A. C., Rocha, V. G., Fernandes, F. J. de A., et al. (2020). Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.02041
NLM
Tozatto-Maio K, Girot R, Ly ID, Silva-Pinto AC, Rocha VG, Fernandes FJ de A, Diagne I, Benzerara Y, Dinardo CL, Soler JMP, Haddad SK, Araujo IL, Kenzey C, Fonseca GHH, Sandoval ESR, Volt F, Jarduli L, Ruggeri A, Mariaselvam C, Gualandro SFM, Rafii H, Cappelli B, Nogueira FM, Scigliuolo GM, Cunha RLG, Farias KCRM de, Simões BP, Gluckman E, Tamouza R. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 maio 12 ] Available from: https://doi.org/10.3389/fimmu.2020.02041
Vancouver
Tozatto-Maio K, Girot R, Ly ID, Silva-Pinto AC, Rocha VG, Fernandes FJ de A, Diagne I, Benzerara Y, Dinardo CL, Soler JMP, Haddad SK, Araujo IL, Kenzey C, Fonseca GHH, Sandoval ESR, Volt F, Jarduli L, Ruggeri A, Mariaselvam C, Gualandro SFM, Rafii H, Cappelli B, Nogueira FM, Scigliuolo GM, Cunha RLG, Farias KCRM de, Simões BP, Gluckman E, Tamouza R. Polymorphisms in inflammatory genes modulate clinical complications in patients with sickle cell disease [Internet]. Frontiers in Immunology. 2020 ; 11[citado 2024 maio 12 ] Available from: https://doi.org/10.3389/fimmu.2020.02041
Artigo de periodico
GVHD-derived plasma as a priming strategy of mesenchymal stem cells (2020)
Silva-Carvalho, Amandda Évelin; Rodrigues, Leane Perim; Schiavinato, Josiane Lilian dos Santos ; Alborghetti, Marcos Rodrigo; Bettarello, Gustavo; Simões, Belinda Pinto ; Neves, Francisco de Assis Rocha; Panepucci, Rodrigo Alexandre; Carvalho, Juliana Lott de; Saldanha-Araujo, Felipe
Source: Stem Cell Research & Therapy. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, LINFÓCITOS, DOENÇA ENXERTO-HOSPEDEIRO, ADJUVANTES IMUNOLÓGICOS, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-CARVALHO, Amandda Évelin et al. GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, v. 11, p. 1-12, 2020Tradução . . Disponível em: https://doi.org/10.1186/s13287-020-01659-x. Acesso em: 12 maio 2024.
APA
Silva-Carvalho, A. É., Rodrigues, L. P., Schiavinato, J. L. dos S., Alborghetti, M. R., Bettarello, G., Simões, B. P., et al. (2020). GVHD-derived plasma as a priming strategy of mesenchymal stem cells. Stem Cell Research & Therapy, 11, 1-12. doi:10.1186/s13287-020-01659-x
NLM
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 maio 12 ] Available from: https://doi.org/10.1186/s13287-020-01659-x
Vancouver
Silva-Carvalho AÉ, Rodrigues LP, Schiavinato JL dos S, Alborghetti MR, Bettarello G, Simões BP, Neves F de AR, Panepucci RA, Carvalho JL de, Saldanha-Araujo F. GVHD-derived plasma as a priming strategy of mesenchymal stem cells [Internet]. Stem Cell Research & Therapy. 2020 ; 11 1-12.[citado 2024 maio 12 ] Available from: https://doi.org/10.1186/s13287-020-01659-x
Artigo de periodico
Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients (2020)
Costa-Pereira, Karla R.; Moraes, Daniela Aparecida; Dias, Juliana Bernardes Elias; Garcia, Juliana Tomé; Oliveira-Cardoso, Érika Arantes de ; Zombrilli, Andréia Ferreira; Leopoldo, Vanessa; Costa, Thalita Melo; Simões, Belinda Pinto ; Oliveira, Maria Carolina
Source: JCR : Journal of Clinical Rheumatology. Unidades: FMRP, FFCLRP
Subjects: REUMATOLOGIA, TRANSPLANTES, CÉLULAS-TRONCO, QUALIDADE DE VIDA, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-PEREIRA, Karla R. et al. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients. JCR : Journal of Clinical Rheumatology, v. 26, n. 7S, p. S131-S138, 2020Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001117. Acesso em: 12 maio 2024.
APA
Costa-Pereira, K. R., Moraes, D. A., Dias, J. B. E., Garcia, J. T., Oliveira-Cardoso, É. A. de, Zombrilli, A. F., et al. (2020). Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients. JCR : Journal of Clinical Rheumatology, 26( 7S), S131-S138. doi:10.1097/RHU.0000000000001117
NLM
Costa-Pereira KR, Moraes DA, Dias JBE, Garcia JT, Oliveira-Cardoso ÉA de, Zombrilli AF, Leopoldo V, Costa TM, Simões BP, Oliveira MC. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients [Internet]. JCR : Journal of Clinical Rheumatology. 2020 ; 26( 7S): S131-S138.[citado 2024 maio 12 ] Available from: https://doi.org/10.1097/RHU.0000000000001117
Vancouver
Costa-Pereira KR, Moraes DA, Dias JBE, Garcia JT, Oliveira-Cardoso ÉA de, Zombrilli AF, Leopoldo V, Costa TM, Simões BP, Oliveira MC. Hematopoietic stem cell transplantation improves functional outcomes of systemic sclerosis patients [Internet]. JCR : Journal of Clinical Rheumatology. 2020 ; 26( 7S): S131-S138.[citado 2024 maio 12 ] Available from: https://doi.org/10.1097/RHU.0000000000001117
Artigo de periodico
Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia (2020)
Oliveira, Milena Locci de ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Pippa, Leandro Francisco ; Simões, Belinda Pinto ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Milena Locci de et al. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, v. 191, p. 1-8, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113576. Acesso em: 12 maio 2024.
APA
Oliveira, M. L. de, Rocha, A., Nardotto, G. H. B., Pippa, L. F., Simões, B. P., & Lanchote, V. L. (2020). Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis, 191, 1-8. doi:10.1016/j.jpba.2020.113576
NLM
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Vancouver
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 191 1-8.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.jpba.2020.113576
Artigo de periodico
A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays (2020)
Tognon, Raquel; Silva, Danillo Cunha de Almeida e ; Rey, Rita Andraos; Ristov, Mitko; Ambrósio, Luciana; Almeida, Felipe Campos de ; Nunes, Natália de Souza; Souto, Elizabeth Xisto; Perobelli, Leila de Lourdes; Simões, Belinda Pinto ; Guthy, Daniel Alexander; Radimerski, Thomas; Castro, Fabíola Attié de
Source: Leukemia & Lymphoma. Unidades: FMRP, FCFRP, BIOINFORMÁTICA
Subjects: NEOPLASIAS, MUTAÇÃO GENÉTICA, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOGNON, Raquel et al. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, v. 61, n. 13, p. 3052-3065, 2020Tradução . . Disponível em: https://doi.org/10.1080/10428194.2020.1805110. Acesso em: 12 maio 2024.
APA
Tognon, R., Silva, D. C. de A. e, Rey, R. A., Ristov, M., Ambrósio, L., Almeida, F. C. de, et al. (2020). A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays. Leukemia & Lymphoma, 61( 13), 3052-3065. doi:10.1080/10428194.2020.1805110
NLM
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 maio 12 ] Available from: https://doi.org/10.1080/10428194.2020.1805110
Vancouver
Tognon R, Silva DC de A e, Rey RA, Ristov M, Ambrósio L, Almeida FC de, Nunes N de S, Souto EX, Perobelli L de L, Simões BP, Guthy DA, Radimerski T, Castro FA de. A proteomic study of myeloproliferative neoplasms using reverse-phase protein arrays [Internet]. Leukemia & Lymphoma. 2020 ; 61( 13): 3052-3065.[citado 2024 maio 12 ] Available from: https://doi.org/10.1080/10428194.2020.1805110
Artigo de periodico
Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia (2020)
Arcuri, Leonardo Javier; Nabhan, Samir Kanaan; Cunha, Renato Luiz Guerino; Nichele, Samantha; Ribeiro, Andreza Alice Feitosa; Fernandes, Juliana Folloni; Daudt, Liane Esteves; Rodrigues, Ana Luiza Melo; Arrais-Rodrigues, Celso; Seber, Adriana; Simões, Belinda Pinto
Source: Biology of Blood and Marrow Transplantation. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ANEMIA, DOADORES DE SANGUE, HEMATOLOGIA, TRANSPLANTE DE MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARCURI, Leonardo Javier et al. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, v. 26, n. 12, p. 2311-2317, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.09.007. Acesso em: 12 maio 2024.
APA
Arcuri, L. J., Nabhan, S. K., Cunha, R. L. G., Nichele, S., Ribeiro, A. A. F., Fernandes, J. F., et al. (2020). Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biology of Blood and Marrow Transplantation, 26( 12), 2311-2317. doi:10.1016/j.bbmt.2020.09.007
NLM
Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007
Vancouver
Arcuri LJ, Nabhan SK, Cunha RLG, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Simões BP. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 12): 2311-2317.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.bbmt.2020.09.007
Artigo de periodico
Differential cytokine network profile in polycythemia vera and secondary polycythemia (2020)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Coelho, Maria Gabriela Berzoti; Tognon, Raquel; Nunes, Natália de Souza ; Simões, Belinda Pinto ; Pereira, Ítalo Sousa; Sartori, Daniela Carlos ; Faccioli, Lucia Helena ; Pontes, Lorena Lobo de Figueiredo ; Frantz, Fabiani Gai ; Castro, Fabíola Attié de
Source: Scientific Reports. Unidades: FMRP, FCFRP
Subjects: INTERLEUCINAS, TRANSTORNOS MIELOPROLIFERATIVOS, FISIOPATOLOGIA, CITOCINAS, NEOPLASIAS, MORTALIDADE, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, v. 10, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-63680-7. Acesso em: 12 maio 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Coelho, M. G. B., Tognon, R., Nunes, N. de S., Simões, B. P., et al. (2020). Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, 10, 1-7. doi:10.1038/s41598-020-63680-7
NLM
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 maio 12 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Vancouver
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 maio 12 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Artigo de periodico
HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches (2020)
Tozatto-Maio, Karina; Torres, Margareth Afonso; Deghaide, Neifi Hassan Saloum; Cardoso, Juliana Fernandes; Volt, Fernanda; Pinto, Ana Cristina Silva; Oliveira, Danielli; Elayoubi, Hanadi; Kashima, Simone; Loiseau, Pascale; Veelken, Hendrik; Ferster, Alina; Cappelli, Barbara; Rodrigues, Evandra Strazza; Scigliuolo, Graziana Maria; Kenzey, Chantal; Ruggeri, Annalisa; Rocha, Vanderson Geraldo ; Simões, Belinda Pinto ; Tamouza, Ryad; Gluckman, Eliane
Source: Biology of Blood and Marrow Transplantation. Unidades: FMRP, FM
Subjects: DOADORES DE SANGUE, TRANSFUSÃO DE SANGUE, ANEMIA FALCIFORME, ANTÍGENOS DE HISTOCOMPATIBILIDADE, DOENÇAS HEMATOLÓGICAS, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO-MAIO, Karina et al. HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches. Biology of Blood and Marrow Transplantation, v. 26, n. 11, p. 2034-2039, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbmt.2020.07.015. Acesso em: 12 maio 2024.
APA
Tozatto-Maio, K., Torres, M. A., Deghaide, N. H. S., Cardoso, J. F., Volt, F., Pinto, A. C. S., et al. (2020). HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches. Biology of Blood and Marrow Transplantation, 26( 11), 2034-2039. doi:10.1016/j.bbmt.2020.07.015
NLM
Tozatto-Maio K, Torres MA, Deghaide NHS, Cardoso JF, Volt F, Pinto ACS, Oliveira D, Elayoubi H, Kashima S, Loiseau P, Veelken H, Ferster A, Cappelli B, Rodrigues ES, Scigliuolo GM, Kenzey C, Ruggeri A, Rocha VG, Simões BP, Tamouza R, Gluckman E. HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 11): 2034-2039.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.015
Vancouver
Tozatto-Maio K, Torres MA, Deghaide NHS, Cardoso JF, Volt F, Pinto ACS, Oliveira D, Elayoubi H, Kashima S, Loiseau P, Veelken H, Ferster A, Cappelli B, Rodrigues ES, Scigliuolo GM, Kenzey C, Ruggeri A, Rocha VG, Simões BP, Tamouza R, Gluckman E. HLA-matched unrelated donors for patients with sickle cell disease: results of international donor searches [Internet]. Biology of Blood and Marrow Transplantation. 2020 ; 26( 11): 2034-2039.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.bbmt.2020.07.015
Trabalho de evento-resumo periodico
Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) (2020)
Kassim, Adetola A.; de la Fuente, Josu; Alahmari, Ali Debsan; Eckrich, Michael J.; Hanna, Rabi; Dhedin, Nathalie; Horn, Biljana N.; Black, Vandy; Gouveia, Roseane V.; Seber, Adriana; Simões, Belinda Pinto ; Costa, Thalita Cristina de Mello; Cunha, Renato Luiz Guerino
Source: Blood. Conference titles: ASH Annual Meeting and Exposition. Unidade: FMRP
Subjects: TRANSPLANTE DE MEDULA ÓSSEA, HEMATOLOGIA, ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KASSIM, Adetola A. et al. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2020-141771. Acesso em: 12 maio 2024. , 2020
APA
Kassim, A. A., de la Fuente, J., Alahmari, A. D., Eckrich, M. J., Hanna, R., Dhedin, N., et al. (2020). Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²). Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2020-141771
NLM
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2024 maio 12 ] Available from: https://doi.org/10.1182/blood-2020-141771
Vancouver
Kassim AA, de la Fuente J, Alahmari AD, Eckrich MJ, Hanna R, Dhedin N, Horn BN, Black V, Gouveia RV, Seber A, Simões BP, Costa TC de M, Cunha RLG. Outcomes of non-myeloablative HLA-haploidentical bone marrow transplant with thiotepa and post-transplant cyclophosphamide in children and adults with severe sickle cell disease, a phase ii trial: Vanderbilt global haploidentical transplant learning collaborative (VGC²) [Internet]. Blood. 2020 ; 136 5 .[citado 2024 maio 12 ] Available from: https://doi.org/10.1182/blood-2020-141771
Artigo de periodico
Emerging aspects of the body composition, bone marrow adipose tissue and skeletal phenotypes in type 1 diabetes mellitus (2019)
Carvalho, Adriana Lelis; Massaro, Bianca ; Silva, Luciana Tabajara Parreiras e; Salmon, Carlos Ernesto Garrido ; Fukada, Sandra Yasuyo ; Nogueira-Barbosa, Marcello Henrique ; Elias Júnior, Jorge ; Foss-Freitas, Maria Cristina ; Couri, Carlos Eduardo Barra; Oliveira, Maria Carolina ; Simões, Belinda Pinto; Rosen, Clifford J.; Paula, Francisco Jose Albuquerque de
Source: Journal of Clinical Densitometry. Unidades: FFCLRP, FCFRP, FMRP
Subjects: OSTEOPOROSE, RESSONÂNCIA MAGNÉTICA, DENSIDADE ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Adriana Lelis et al. Emerging aspects of the body composition, bone marrow adipose tissue and skeletal phenotypes in type 1 diabetes mellitus. Journal of Clinical Densitometry, v. 22, n. 3, p. 420-428, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jocd.2018.06.007. Acesso em: 12 maio 2024.
APA
Carvalho, A. L., Massaro, B., Silva, L. T. P. e, Salmon, C. E. G., Fukada, S. Y., Nogueira-Barbosa, M. H., et al. (2019). Emerging aspects of the body composition, bone marrow adipose tissue and skeletal phenotypes in type 1 diabetes mellitus. Journal of Clinical Densitometry, 22( 3), 420-428. doi:10.1016/j.jocd.2018.06.007
NLM
Carvalho AL, Massaro B, Silva LTP e, Salmon CEG, Fukada SY, Nogueira-Barbosa MH, Elias Júnior J, Foss-Freitas MC, Couri CEB, Oliveira MC, Simões BP, Rosen CJ, Paula FJA de. Emerging aspects of the body composition, bone marrow adipose tissue and skeletal phenotypes in type 1 diabetes mellitus [Internet]. Journal of Clinical Densitometry. 2019 ; 22( 3): 420-428.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.jocd.2018.06.007
Vancouver
Carvalho AL, Massaro B, Silva LTP e, Salmon CEG, Fukada SY, Nogueira-Barbosa MH, Elias Júnior J, Foss-Freitas MC, Couri CEB, Oliveira MC, Simões BP, Rosen CJ, Paula FJA de. Emerging aspects of the body composition, bone marrow adipose tissue and skeletal phenotypes in type 1 diabetes mellitus [Internet]. Journal of Clinical Densitometry. 2019 ; 22( 3): 420-428.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.jocd.2018.06.007

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration